These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 22046416)

  • 41. Expression of SV2 isoforms during rodent brain development.
    Crèvecœur J; Foerch P; Doupagne M; Thielen C; Vandenplas C; Moonen G; Deprez M; Rogister B
    BMC Neurosci; 2013 Aug; 14():87. PubMed ID: 23937191
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Biallelic variants in the synaptic vesicle glycoprotein 2 A are associated with epileptic encephalopathy.
    Al-Maawali A; Al-Murshedi F; Al-Futaisi A; Mansy A; Al-Habsi A; Girisha KM
    Eur J Hum Genet; 2024 Feb; 32(2):243-246. PubMed ID: 37985816
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Brain chimeras for the study of an avian model of genetic epilepsy: structures involved in sound and light-induced seizures.
    Fadlallah N; Guy N; Teillet MA; Schuler B; Le Douarin NM; Naquet R; Batini C
    Brain Res; 1995 Mar; 675(1-2):55-66. PubMed ID: 7796153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Synaptic vesicle protein 2A predicts response to levetiracetam in patients with glioma.
    de Groot M; Aronica E; Heimans JJ; Reijneveld JC
    Neurology; 2011 Aug; 77(6):532-9. PubMed ID: 21795655
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Genetic animal models of epilepsy as a unique resource for the evaluation of anticonvulsant drugs. A review.
    Löscher W
    Methods Find Exp Clin Pharmacol; 1984 Sep; 6(9):531-47. PubMed ID: 6439966
    [TBL] [Abstract][Full Text] [Related]  

  • 46. A Mitochondrial Role of SV2a Protein in Aging and Alzheimer's Disease: Studies with Levetiracetam.
    Stockburger C; Miano D; Baeumlisberger M; Pallas T; Arrey TN; Karas M; Friedland K; Müller WE
    J Alzheimers Dis; 2016; 50(1):201-15. PubMed ID: 26639968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Levetiracetam treatment ameliorates LRRK2 pathological mutant phenotype.
    Rassu M; Biosa A; Galioto M; Fais M; Sini P; Greggio E; Piccoli G; Crosio C; Iaccarino C
    J Cell Mol Med; 2019 Dec; 23(12):8505-8510. PubMed ID: 31560168
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Integration of postmortem amygdala expression profiling, GWAS, and functional cell culture assays: neuroticism-associated synaptic vesicle glycoprotein 2A (SV2A) gene is regulated by miR-133a and miR-218.
    Jurkiewicz M; Moser D; Koller A; Yu L; Chen EI; Bennett DA; Canli T
    Transl Psychiatry; 2020 Aug; 10(1):297. PubMed ID: 32839459
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Altered balance between excitatory and inhibitory inputs onto CA1 pyramidal neurons from SV2A-deficient but not SV2B-deficient mice.
    Venkatesan K; Alix P; Marquet A; Doupagne M; Niespodziany I; Rogister B; Seutin V
    J Neurosci Res; 2012 Dec; 90(12):2317-27. PubMed ID: 22847229
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Levetiracetam reverses synaptic deficits produced by overexpression of SV2A.
    Nowack A; Malarkey EB; Yao J; Bleckert A; Hill J; Bajjalieh SM
    PLoS One; 2011; 6(12):e29560. PubMed ID: 22220214
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preferential increase in the hippocampal synaptic vesicle protein 2A (SV2A) by pentylenetetrazole kindling.
    Ohno Y; Ishihara S; Terada R; Kikuta M; Sofue N; Kawai Y; Serikawa T; Sasa M
    Biochem Biophys Res Commun; 2009 Dec; 390(3):415-20. PubMed ID: 19751703
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Brivaracetam Prevents the Over-expression of Synaptic Vesicle Protein 2A and Rescues the Deficits of Hippocampal Long-term Potentiation In Vivo in Chronic Temporal Lobe Epilepsy Rats.
    Ge YX; Lin YY; Bi QQ; Chen YJ
    Curr Neurovasc Res; 2020; 17(4):354-360. PubMed ID: 32407277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Analysis of Differential Expression of Synaptic Vesicle Protein 2A in the Adult Rat Brain.
    Mendoza-Torreblanca JG; García-Cruz ME; Sánchez-Cruz I; Gomez-Gonzalez B; Juárez-Méndez S; Gómez-Lira G
    Neuroscience; 2019 Nov; 419():108-120. PubMed ID: 31520710
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Discovery of heterocyclic nonacetamide synaptic vesicle protein 2A (SV2A) ligands with single-digit nanomolar potency: opening avenues towards the first SV2A positron emission tomography (PET) ligands.
    Mercier J; Archen L; Bollu V; Carré S; Evrard Y; Jnoff E; Kenda B; Lallemand B; Michel P; Montel F; Moureau F; Price N; Quesnel Y; Sauvage X; Valade A; Provins L
    ChemMedChem; 2014 Apr; 9(4):693-8. PubMed ID: 24446373
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacological Profile of the Novel Antiepileptic Drug Candidate Padsevonil: Interactions with Synaptic Vesicle 2 Proteins and the GABA
    Wood M; Daniels V; Provins L; Wolff C; Kaminski RM; Gillard M
    J Pharmacol Exp Ther; 2020 Jan; 372(1):1-10. PubMed ID: 31619465
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Development of epileptic activity in embryos and newly hatched chicks of the Fayoumi mutant chicken.
    Guy NT; Fadlallah N; Naquet R; Batini C
    Epilepsia; 1995 Jan; 36(1):101-7. PubMed ID: 8001501
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Modulation of the conformational state of the SV2A protein by an allosteric mechanism as evidenced by ligand binding assays.
    Daniels V; Wood M; Leclercq K; Kaminski RM; Gillard M
    Br J Pharmacol; 2013 Jul; 169(5):1091-101. PubMed ID: 23530581
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Identification of the antiepileptic racetam binding site in the synaptic vesicle protein 2A by molecular dynamics and docking simulations.
    Correa-Basurto J; Cuevas-Hernández RI; Phillips-Farfán BV; Martínez-Archundia M; Romo-Mancillas A; Ramírez-Salinas GL; Pérez-González ÓA; Trujillo-Ferrara J; Mendoza-Torreblanca JG
    Front Cell Neurosci; 2015; 9():125. PubMed ID: 25914622
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A
    Calame DG; Herman I; Riviello JJ
    Epilepsy Behav Rep; 2021; 15():100425. PubMed ID: 33554103
    [No Abstract]   [Full Text] [Related]  

  • 60. SV2 regulates neurotransmitter release via multiple mechanisms.
    Nowack A; Yao J; Custer KL; Bajjalieh SM
    Am J Physiol Cell Physiol; 2010 Nov; 299(5):C960-7. PubMed ID: 20702688
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.